Windlas Biotech Limited (WINDLAS.BO)
INR 924.95
(-0.21%)
INR 924.95
(-0.21%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.29 Billion INR | 34.46% |
| 2022 | 481.4 Million INR | 21.11% |
| 2021 | 397.48 Million INR | -8.83% |
| 2020 | 435.98 Million INR | 34.12% |
| 2019 | 325.06 Million INR | 15.25% |
| 2018 | 282.05 Million INR | 25.5% |
| 2017 | 224.74 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 146.7 Million INR | -20.57% |
| 2023 Q2 | 153.57 Million INR | 10.05% |
| 2023 Q3 | 169.48 Million INR | 10.36% |
| 2023 FY | 647.28 Million INR | 34.46% |
| 2023 Q1 | 139.54 Million INR | 8.41% |
| 2023 Q4 | 184.69 Million INR | 8.97% |
| 2022 Q2 | 131.4 Million INR | 19.06% |
| 2022 FY | 481.4 Million INR | 21.11% |
| 2022 Q4 | 128.72 Million INR | 19.03% |
| 2022 Q3 | 108.14 Million INR | -17.7% |
| 2022 Q1 | 110.36 Million INR | 0.89% |
| 2021 Q4 | 109.39 Million INR | 10.53% |
| 2021 FY | 397.48 Million INR | -8.83% |
| 2021 Q3 | 98.97 Million INR | -1.82% |
| 2021 Q2 | 100.8 Million INR | 7.69% |
| 2021 Q1 | 93.6 Million INR | 18.38% |
| 2020 Q4 | 79.07 Million INR | -47.38% |
| 2020 Q3 | 150.28 Million INR | 55.36% |
| 2020 Q1 | 108.78 Million INR | 117.95% |
| 2020 Q2 | 96.73 Million INR | -11.08% |
| 2020 FY | 435.98 Million INR | 34.12% |
| 2019 FY | 325.06 Million INR | 15.25% |
| 2019 Q4 | 49.91 Million INR | 0.0% |
| 2018 FY | 282.05 Million INR | 25.5% |
| 2017 FY | 224.74 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 77.442% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 96.922% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 85.534% |
| Granules India Limited | 6.81 Billion INR | 80.946% |
| Indoco Remedies Limited | 1.29 Billion INR | -0.491% |
| Achyut Healthcare Limited | 4.43 Million INR | -29167.463% |
| Ajanta Pharma Limited | 19.67 Billion INR | 93.399% |
| Alkem Laboratories Limited | 19.46 Billion INR | 93.326% |
| Alpa Laboratories Limited | 184.49 Million INR | -604.017% |
| Brooks Laboratories Limited | 14.44 Million INR | -8895.083% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | 24.373% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -5.515% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 98.082% |
| Eris Lifesciences Limited | 5.18 Billion INR | 74.933% |
| FDC Limited | 2.98 Billion INR | 56.504% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 80.024% |
| Gufic Biosciences Limited | 1.32 Billion INR | 2.332% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | 70.617% |
| Ipca Laboratories Limited | 7.98 Billion INR | 83.724% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | -155.622% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | 954.775% |
| Lasa Supergenerics Limited | -458 Million INR | 383.597% |
| Laurus Labs Limited | 3.94 Billion INR | 67.105% |
| Lupin Limited | 28.04 Billion INR | 95.368% |
| Mankind Pharma Limited | 21.51 Billion INR | 93.964% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Medico Remedies Limited | 100.3 Million INR | -1195.005% |
| Megasoft Limited | -121.1 Million INR | 1172.541% |
| NATCO Pharma Limited | 25.96 Billion INR | 94.997% |
| Piramal Pharma Limited | 4.55 Billion INR | 71.496% |
| RPG Life Sciences Limited | 2.29 Billion INR | 43.337% |
| Sigachi Industries Limited | 1.47 Billion INR | 11.874% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 98.755% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 71.81% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -421.117% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Wanbury Limited | 569.71 Million INR | -127.989% |
| ZIM Laboratories Limited | 253.82 Million INR | -411.719% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 96.987% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 131.564% |
| Divi's Laboratories Limited | 33.08 Billion INR | 96.073% |
| Hester Biosciences Limited | 364.81 Million INR | -256.046% |
| Procter & Gamble Health Limited | 2.78 Billion INR | 53.378% |
| Amrutanjan Health Care Limited | 457.54 Million INR | -183.883% |
| Bal Pharma Limited | 233.9 Million INR | -455.297% |
| Strides Pharma Science Limited | 5.22 Billion INR | 75.145% |
| Venus Remedies Limited | 534.65 Million INR | -142.942% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | 58.477% |
| Nectar Lifesciences Limited | 923.8 Million INR | -40.602% |
| Shilpa Medicare Limited | 1.36 Billion INR | 4.932% |
| Aarti Drugs Limited | 7.14 Billion INR | 81.83% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | 18.657% |
| Suven Life Sciences Limited | -1.22 Billion INR | 205.961% |
| Ind-Swift Limited | 1.22 Billion INR | -5.948% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | 90.906% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 133.712% |
| Themis Medicare Limited | 392.58 Million INR | -230.852% |
| Hikal Limited | 32.11 Million INR | -3945.126% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 94.873% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Novartis India Limited | 626.5 Million INR | -107.325% |
| Wockhardt Limited | -670 Million INR | 293.864% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 74.968% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -14222.781% |
| Neuland Laboratories Limited | 5.31 Billion INR | 75.576% |
| Morepen Laboratories Limited | 4.17 Billion INR | 68.88% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -524.316% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -4630.461% |